MALAT1 and cancer: In colorectal cancer (CRC), suppression of MALAT1 restrained cell progression by downregulation of the expression of ABC, MDR1, MRP1, and breast cancer drug resistant proteins through targeting miR-20b-5p, resulting in drug resistance of cancer cells to 5-FU [59].